Vera Therapeutics, Inc. (VERA)
NASDAQ·Healthcare·Biotechnology
$37.05
-0.47%
Mkt Cap $2.69B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | — | — | — | -$1.34 | -$1.39 | -3.73% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$1.20 | -$1.26 | -5.00% | — | — |
| Q3 2025 Aug 5, 2025 | — | — | — | -$0.82 | -$1.20 | -46.34% | — | — |
| Q2 2025 May 6, 2025 | — | — | — | -$0.75 | -$0.81 | -8.00% | — | — |
| Q1 2025 Feb 26, 2025 | — | — | — | -$0.83 | -$0.72 | +13.25% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.69 | -$0.85 | -23.19% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.58 | -$0.62 | -6.90% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.53 | -$0.56 | -5.66% | — | — |
| Q1 2024 Mar 20, 2024 | — | — | — | -$0.53 | -$0.58 | -9.43% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.50 | -$0.45 | +10.00% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.69 | -$0.46 | +33.33% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.60 | -$0.80 | -33.33% | — | — |
| Q1 2023 Mar 28, 2023 | — | — | — | -$0.93 | -$1.19 | -27.96% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$0.72 | -$0.91 | -26.39% | — | — |
| Q3 2022 Aug 10, 2022 | — | — | — | -$0.72 | -$0.55 | +23.61% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.67 | -$0.71 | -5.97% | — | — |
| Q1 2022 Mar 24, 2022 | — | — | — | -$0.49 | -$0.79 | -61.22% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.60 | -$0.36 | +40.00% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.39 | -$0.33 | +15.38% | — | — |
| Q2 2021 Jun 24, 2021 | — | — | — | -$1.94 | -$12.23 | -530.41% | — | — |